Yes, OK.
But since they say 'There are no active clinical studies with this product at the moment', I still think $465 million dollars is a lot for a company to pay for something in which they have no ongoing clinical studies, even if they can afford it. Hell, if they go on buying up eye drops like that, they'd be bankrupt in no time at all. When those guys go shopping, they go wild!
Better let them know how worried we are about their financial health!